Guarini Kathryn — SEC insider filings
SEC reporting owner CIK 1992352. 7 insider filings on record with FilingPulse; latest filed 2026-11-03.
Transaction summary — filings shown
Covers all 7 filings on record, filed 2023-09-12 to 2026-11-03. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 3 legs across 3 filings — 1,200 shares, $1,020,000 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 14.
- Largest priced transaction: sale of 400 shares @ $900.00 ($360,000) in REGENERON PHARMACEUTICALS, INC., filed 2026-11-03.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| REGENERON PHARMACEUTICALS, INC. (REGN) | Director | 7 | — | 3 legs · 1,200 sh · $1,020,000 | 14 |
Insider filings — Guarini Kathryn
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-11-03 | 4 | REGENERON PHARMACEUTICALS, INC. (REGN) | Option exercise (M): 400 @ $719.37 · Sale (S): 400 @ $900 · Option exercise (M): 400 (derivative) @ $0 | EDGAR |
| 2026-09-03 | 4 | REGENERON PHARMACEUTICALS, INC. (REGN) | Option exercise (M): 400 @ $719.37 · Sale (S): 400 @ $850 · Option exercise (M): 400 (derivative) @ $0 | EDGAR |
| 2026-08-12 | 4 | REGENERON PHARMACEUTICALS, INC. (REGN) | Option exercise (M): 400 @ $719.37 · Sale (S): 400 @ $800 · Option exercise (M): 400 (derivative) @ $0 | EDGAR |
| 2026-01-06 | 4 | REGENERON PHARMACEUTICALS, INC. (REGN) | Grant/award (A): 155 @ $0 · Grant/award (A): 1,962 (derivative) @ $0 | EDGAR |
| 2025-01-06 | 4 | REGENERON PHARMACEUTICALS, INC. (REGN) | Grant/award (A): 166 @ $0 · Grant/award (A): 1,958 (derivative) @ $0 | EDGAR |
| 2024-01-04 | 4 | REGENERON PHARMACEUTICALS, INC. (REGN) | Grant/award (A): 42 @ $0 · Grant/award (A): 508 (derivative) @ $0 | EDGAR |
| 2023-09-12 | 4 | REGENERON PHARMACEUTICALS, INC. (REGN) | Grant/award (A): 240 @ $0 · Grant/award (A): 2,739 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2021-05-18 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1992352 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs